GemOx regimen: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx. ==Regimen== {{chemo|x|xx}} {{chemo|x|xx}}...")
 
No edit summary
 
Line 3: Line 3:
{{CMG}}; {{AE}} {{AV}}
{{CMG}}; {{AE}} {{AV}}


{{SK}}
{{SK}}GEM-OX Regimen; Gemcitabine-Oxaliplatin Regimen; GEMOX Regimen


==Overview==
==Overview==
{{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx.
{{PAGENAME}} refers to a regimen consisting of [[gemcitabine]] and [[oxaliplatin]] used for the treatment of [[adenocarcinoma|biliary adenocarcinoma]], [[pancreatic cancer]], [[Hepatocellular carcinoma|hepatocellular cancer]]<ref name="pmid24748335">{{cite journal| author=Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L et al.| title=Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies. | journal=Invest New Drugs | year= 2014 | volume= 32 | issue= 5 | pages= 1028-35 | pmid=24748335 | doi=10.1007/s10637-014-0100-y | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24748335  }} </ref> and [[testicular cancer]]<ref name="pmid14998855">{{cite journal| author=Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M et al.| title=Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study. | journal=Ann Oncol | year= 2004 | volume= 15 | issue= 3 | pages= 493-7 | pmid=14998855 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14998855  }} </ref>. This regimen is currently being studied in a variety of other cancers.


==Regimen==
==Regimen==
{{chemo|x|xx}}
{{chemo|Gem|Gemcitabine}}


{{chemo|x|xx}}
{{chemo|Ox|Oxaliplatin}}
 
{{chemo|x|xx}}
 
{{chemo|x|xx}}


==Indications==
==Indications==
 
*[[adenocarcinoma|Biliary adenocarcinoma]],
*[[Pancreatic cancer]],
*[[Hepatocellular carcinoma|Hepatocellular cancer]]<ref name="pmid24748335">{{cite journal| author=Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L et al.| title=Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies. | journal=Invest New Drugs | year= 2014 | volume= 32 | issue= 5 | pages= 1028-35 | pmid=24748335 | doi=10.1007/s10637-014-0100-y | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24748335  }} </ref>
*[[Testicular cancer]]<ref name="pmid14998855">{{cite journal| author=Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M et al.| title=Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study. | journal=Ann Oncol | year= 2004 | volume= 15 | issue= 3 | pages= 493-7 | pmid=14998855 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14998855  }} </ref>


==References==
==References==

Latest revision as of 19:13, 26 March 2015

WikiDoc Resources for GemOx regimen

Articles

Most recent articles on GemOx regimen

Most cited articles on GemOx regimen

Review articles on GemOx regimen

Articles on GemOx regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on GemOx regimen

Images of GemOx regimen

Photos of GemOx regimen

Podcasts & MP3s on GemOx regimen

Videos on GemOx regimen

Evidence Based Medicine

Cochrane Collaboration on GemOx regimen

Bandolier on GemOx regimen

TRIP on GemOx regimen

Clinical Trials

Ongoing Trials on GemOx regimen at Clinical Trials.gov

Trial results on GemOx regimen

Clinical Trials on GemOx regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on GemOx regimen

NICE Guidance on GemOx regimen

NHS PRODIGY Guidance

FDA on GemOx regimen

CDC on GemOx regimen

Books

Books on GemOx regimen

News

GemOx regimen in the news

Be alerted to news on GemOx regimen

News trends on GemOx regimen

Commentary

Blogs on GemOx regimen

Definitions

Definitions of GemOx regimen

Patient Resources / Community

Patient resources on GemOx regimen

Discussion groups on GemOx regimen

Patient Handouts on GemOx regimen

Directions to Hospitals Treating GemOx regimen

Risk calculators and risk factors for GemOx regimen

Healthcare Provider Resources

Symptoms of GemOx regimen

Causes & Risk Factors for GemOx regimen

Diagnostic studies for GemOx regimen

Treatment of GemOx regimen

Continuing Medical Education (CME)

CME Programs on GemOx regimen

International

GemOx regimen en Espanol

GemOx regimen en Francais

Business

GemOx regimen in the Marketplace

Patents on GemOx regimen

Experimental / Informatics

List of terms related to GemOx regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:GEM-OX Regimen; Gemcitabine-Oxaliplatin Regimen; GEMOX Regimen

Overview

GemOx regimen refers to a regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer[1] and testicular cancer[2]. This regimen is currently being studied in a variety of other cancers.

Regimen

GemGemcitabine

OxOxaliplatin

Indications

References

  1. 1.0 1.1 Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L; et al. (2014). "Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies". Invest New Drugs. 32 (5): 1028–35. doi:10.1007/s10637-014-0100-y. PMID 24748335.
  2. 2.0 2.1 Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M; et al. (2004). "Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study". Ann Oncol. 15 (3): 493–7. PMID 14998855.